IDEXX Laboratories (IDXX) Earnings Date, Estimates & Call Transcripts $451.41 -0.86 (-0.19%) (As of 10/25/2024 08:56 PM ET) Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Earnings SummaryUpcoming Earnings DateOct. 31Before Market OpensConfirmedActual EPS (Aug. 6) $2.44 Missed By -$0.44 Consensus EPS (Aug. 6) $2.88 Conference Call TranscriptConference Call AudioEarnings Press ReleaseEarnings Slide Deck Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueIDXX Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.IDXX Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad DTIThe gold trades I'm making right nowBack in November, gold made a tiny move of 1.6%. But using a special type of gold trade, I saw a 141% gain in just a week. It happened again in March. Gold nudged up 1.2%. This time? A 104% overnight gain. And in June? A 1% gold move turned into a 74% gain in two weeks. Granted, there were smaller wins and those that did not work out, but you see, there's a reason I'm telling all my friends to hold off from buying gold or regular gold stocks right now. There's a more lucrative way to play the gold market as we enter a new breakout period.It's all about catching what I call "Acceleration Cycles." IDEXX Laboratories Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany GuidanceQ1 20242$2.55$2.72$2.64 Q2 20242$2.84$2.86$2.85 Q3 20242$2.69$2.78$2.74 Q4 20242$2.62$2.91$2.77 FY 20248$10.70$11.27$10.99 Q1 20252$2.96$3.08$3.02 Q2 20252$3.00$3.19$3.10 Q3 20252$3.13$3.15$3.14 Q4 20251$3.16$3.16$3.16 FY 20257$12.25$12.58$12.42 Q1 20261$3.55$3.55$3.55 Q3 20261$3.51$3.51$3.51 IDXX Earnings Date and InformationIDEXX Laboratories last announced its quarterly earnings results on August 6th, 2024. The reported $2.44 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $2.88 by $0.44. The business had revenue of $1 billion for the quarter, compared to analysts' expectations of $1.01 billion. Its quarterly revenue was up 6.4% compared to the same quarter last year. IDEXX Laboratories has generated $10.33 earnings per share over the last year ($10.33 diluted earnings per share) and currently has a price-to-earnings ratio of 44.7. Earnings for IDEXX Laboratories are expected to grow by 17.82% in the coming year, from $10.44 to $12.30 per share. IDEXX Laboratories has confirmed that its next quarterly earnings report will be published on Thursday, October 31st, 2024. IDEXX Laboratories will be holding an earnings conference call on Thursday, October 31st at 8:30 AM Eastern. Interested parties can register for or listen to the call.. Read More IDEXX Laboratories Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueLinks 10/31/2024(Confirmed)------- 8/6/2024Q2 2024$2.88$2.44($0.44)$2.44$1.01 billion$1.00 billion 5/1/2024Q1 2024$2.68$2.81+$0.13$2.81$965.43 million$964.10 million 2/5/2024Q4 2023$2.12$2.32+$0.20$2.32$891.88 million$901.60 million 11/1/2023Q3 2023$2.37$2.53+$0.16$2.53$926.88 million$915.53 million 8/1/2023Q2 2023$2.43$2.67+$0.24$2.67$927.84 million$943.63 million 5/2/2023Q1 2023$2.38$2.55+$0.17$2.55$887.36 million$900.20 million “Buffett Indicator” Predicts 62% Stock Market Crash (Ad)The last time the "Buffett Indicator" flashed this red was in 2000 - right before the market crashed 50%.Take these 4 steps to protect your retirement here >>>2/6/2023Q4 2022$1.92$2.05+$0.13$2.05$820.91 million$828.60 million 11/1/2022Q3 2022$2.04$2.15+$0.11$2.15$829.23 million$841.66 million 8/2/2022Q2 2022$1.54$1.56+$0.02$1.56$864.26 million$860.55 million 5/4/2022Q1 2022$2.25$2.27+$0.02$2.27$836.47 million$836.55 million 2/2/2022Q4 2021$1.67$1.89+$0.22$1.89$781.83 million$801.00 million 11/2/2021Q3 2021$1.88$2.03+$0.15$2.03$793.26 million$810.42 million 7/30/2021Q2 2021$2.01$2.34+$0.33$2.34$794.64 million$826.14 million 5/4/2021Q1 2021$1.72$2.35+$0.63$2.35$738.43 million$777.71 million 2/2/2021Q4 2020$1.39$2.01+$0.62$2.01$680.03 million$720.90 million 10/29/2020Q3 2020$1.42$1.69+$0.27$1.69$672.48 million$721.79 million 7/31/2020Q2 2020$1.17$1.72+$0.55$1.72$589.98 million$637.20 million 4/30/2020Q1 2020$1.20$1.29+$0.09$1.29$616.87 million$626.30 million 1/31/2020Q4 2019$0.91$1.04+$0.13$1.04$600.60 million$605.50 million 10/31/2019Q3 2019$1.14$1.24+$0.10$1.24$597.09 million$605.30 million IDEXX Laboratories Earnings - Frequently Asked Questions When is IDEXX Laboratories's earnings date? IDEXX Laboratories has confirmed that its next quarterly earnings data will be published on Thursday, October 31st, 2024. Learn more on IDXX's earnings history. What guidance has IDEXX Laboratories issued on next quarter's earnings? IDEXX Laboratories issued an update on its FY 2024 earnings guidance on Tuesday, August, 6th. The company provided EPS guidance of 10.310-10.590 for the period, compared to the consensus earnings per share estimate of 11.050. The company issued revenue guidance of $3.9 billion-$3.9 billion, compared to the consensus revenue estimate of $3.9 billion. Did IDEXX Laboratories beat their earnings estimates last quarter? In the previous quarter, IDEXX Laboratories (NASDAQ:IDXX) missed the analysts' consensus estimate of $2.88 by $0.44 with a reported earnings per share (EPS) of $2.44. Learn more on analysts' earnings estimate vs. IDXX's actual earnings. How can I listen to IDEXX Laboratories's earnings conference call? The conference call for IDEXX Laboratories's latest earnings report can be listened to online. Listen to Conference Call How can I read IDEXX Laboratories's conference call transcript? The conference call transcript for IDEXX Laboratories's latest earnings report can be read online. Read Transcript How much revenue does IDEXX Laboratories generate each year? IDEXX Laboratories (NASDAQ:IDXX) has a recorded annual revenue of $3.78 billion. How much profit does IDEXX Laboratories generate each year? IDEXX Laboratories (NASDAQ:IDXX) has a recorded net income of $845.04 million. IDXX has generated $10.33 earnings per share over the last four quarters. What is IDEXX Laboratories's price-to-earnings ratio? IDEXX Laboratories (NASDAQ:IDXX) has a trailing price-to-earnings ratio of 44.69 and a forward price-to-earnings ratio of 43.24. The price/earnings-to-growth ratio is 4.03. What is IDEXX Laboratories's EPS forecast for next year? IDEXX Laboratories's earnings are expected to grow from $10.44 per share to $12.30 per share in the next year, which is a 17.82% increase. ` More Earnings Resources from MarketBeat Related Companies Stryker Earnings Date Boston Scientific Earnings Date Medtronic Earnings Date Becton, Dickinson and Company Earnings Date Edwards Lifesciences Earnings Date ResMed Earnings Date DexCom Earnings Date STERIS Earnings Date Hologic Earnings Date Baxter International Earnings Date Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Lam Research Proves Analysts Wrong with a Strong Earnings ReportPulteGroup Earnings Signal Potential Entry Points for InvestorsTaiwan Semiconductor Soars on Earnings With More Room to RunBank of America Earnings Uncover Shifts in Consumer SpendingGoldman Sachs Earnings Reveal Market Moves Investors Can't IgnoreNike’s Post-Earnings Drop Presents a Buying OpportunityMicron Stock Soars as AI Demand Fuels Big Q4 Earnings Beat This page (NASDAQ:IDXX) was last updated on 10/28/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredInvest in the company that won over the DragonsThe pioneer in smart-doorbell technology, RING, pitched their business on the hit show Shark Tank at a valuati...RYSE | SponsoredCountdown to Chaos begins WednesdayWill it be Trump or Harris? In an exclusive interview on Wednesday, October 30, at 8 p.m. ET, he’ll explain...Brownstone Research | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored[Urgent] Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it a...Paradigm Press | SponsoredWe recommended Nvidia in 2016, now we’re recommending this…The AI boom is just getting started. And the real wealth has still to be made…Porter & Company | SponsoredTiny Defense Firm Set for Huge Gains with New US ContractOne tiny defense firm just won a groundbreaking US military contract… That could hand early investors gains...Behind the Markets | SponsoredAI Detects Profit Surge On MondayThis has given investors the opportunity to beat the market by 1,700% and a 100% win rate to begin the year.Monument Traders Alliance | Sponsored Adding Choose a watchlist: Watchlist My Default Watchlist Adding IDEXX Laboratories, Inc. You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Please log in to your account or sign up in order to add this asset to your watchlist. Share IDEXX Laboratories With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Questions? Get Started with MarketBeat — Read Your Daily NewsletterCheck Out My MarketBeatWatch Our Tutorial VideosAdd a Stock to Your WatchlistSet Up an Instant AlertView a Company's Profile PageView Our Financial CalendarsView Today's Analyst Ratings Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
